Mexico Healthcare news | Sharemaestro Newsreel

13:28 13 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

BD (BDX) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations - Shawn Bevec Chairman, Chief Executive Officer and President - Tom Polen Executive Vice President and Chief Financial Officer - Vitor Roque Full …

BDX main company

Sharemaestro market context Price below Trend Line 52 weeks -20.7% · Next-week setup negative 16.7%

13:01 13 Aug 2026

nasdaq.com Earnings Main company 🇲🇽 Mexico

Zoetis (ZTS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Steve FrankChief Executive Officer - Kristin PeckChief Financial Officer - Wetteny Joseph TAKEAWAYS Revenue -- $2.5 billion, representing a flat result on …

ZTS main company

Sharemaestro market context Price below Trend Line 52 weeks -56.9%

13:00 13 Aug 2026

finance.yahoo.com Deals and strategy Provider-linked mention 🇲🇽 Mexico

MeiraGTx Reports Second Quarter 2026 Financial and Operational Results

MeiraGTx Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 and reported positive three-year data from Phase 1 AQUAx clinical trial evaluating AAV2-hAQP1 for the treatment of moderate to severe grade 2/3 radiation-induced xerostomia Completed the acquisition of all interests and rights to botaretigene sparoparvovec (bota-vec) …

JNJ mentioned

Sharemaestro market context Trend signal active 52 weeks +32.5%

10:11 13 Aug 2026

finance.yahoo.com Capital return Main company 🇲🇽 Mexico

Why Gilead Sciences (GILD) Is Back In The Spotlight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Gilead Sciences (GILD) is back in focus after announcing a collaboration with Nucleai that applies AI powered tissue analytics to its antibody drug conjugate …

GILD main company

Sharemaestro market context Price below Trend Line 52 weeks +4.3%

05:43 13 Aug 2026

finance.yahoo.com Market update Main company 🇲🇽 Mexico

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on …

MDTN main company

Sharemaestro market context Price below Trend Line 52 weeks -10.1% · Next-week setup negative 28.6%

04:17 13 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical has seen its assessed fair value cut from US$107.42 to US$103.23, a modest 3.9% trim that reflects a cooler view on …

GMED main company

Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2%

03:29 13 Aug 2026

finance.yahoo.com Market update Main company 🇲🇽 Mexico

5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call

5 Insightful Analyst Questions From Pfizer's Q2 Earnings Call Pfizer's second quarter results reflected stability in its core business despite ongoing challenges in COVID-related product demand. The company's performance was shaped by strong execution in its non-COVID portfolio, with management highlighting robust revenue contributions …

PFE main company

Sharemaestro market context Price above Trend Line 52 weeks -2.9%

03:10 13 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Will Strong Q2 2026 Results and New Cardiac Test Change IDEXX Laboratories' (IDXX) Narrative?

IDEXX Laboratories recently reported past second-quarter 2026 results showing higher revenue and earnings, and slightly raised its full-year 2026 guidance for revenue, operating margin and EPS. The company also introduced the Catalyst proBNP Test, the first dual-species, in-clinic NT-proBNP cardiac test, expanding its connected …

IDXX main company

Sharemaestro market context Price above Trend Line 52 weeks -16.0% · Next-week setup negative 35.2%

03:09 13 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Is Globus Medical (GMED) A Bargain On Its Zacks Upgrade And Reaffirmed Guidance?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical (GMED) has been in focus after a recent upgrade to Zacks Rank #1, which came shortly after the company reaffirmed its …

GMED main company

Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2%

02:10 13 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

CEZ AS (XPRA:CEZ) (Q2 2026) Earnings Call Highlights: Net Income Rises 10% as Windfall Tax ...

This article first appeared on GuruFocus. Revenue: Operating revenue decreased 5% year-on-year, primarily due to lower power prices. EBITDA: Down 20% to CZK59 billion, impacted by lower generation prices and reduced trading profits. Net Income: Increased 10% to CZK18.1 billion, driven by the absence …

BAYNN mentioned

Sharemaestro market context Price above Trend Line 52 weeks +47.4% · Next-week setup negative 19.6%

02:05 13 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

GFT Technologies SE (WBO:GFT) (H1 2026) Earnings Call Highlights: AI-Driven Growth and ...

This article first appeared on GuruFocus. Revenue: EUR462.6 million in H1 2026, a 5% increase in both euros and constant currencies. Adjusted EBIT: EUR33 million, up 8% year-over-year, with a margin of 7.1% compared to 6.8% in H1 2025. EBT: EUR24 million, up 26% …

BAYNN mentioned

Sharemaestro market context Price above Trend Line 52 weeks +47.4% · Next-week setup negative 19.6%

01:58 13 Aug 2026

nasdaq.com Earnings Main company 🇲🇽 Mexico

Inovio (INO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Director of Communications - Jennie WillsonPresident and Chief Executive Officer - Dr. Jacqueline E. SheaChief Medical Officer - Dr. Michael SumnerChief Commercial Officer - Steven EggeChief Financial Officer …

INO main company

Sharemaestro market context Price below Trend Line 52 weeks -62.2% · Next-week setup negative 34.3%

00:41 13 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

5 Insightful Analyst Questions From Merck’s Q2 Earnings Call

5 Insightful Analyst Questions From Merck's Q2 Earnings Call Merck's second quarter was marked by continued sales growth, primarily driven by the strength of its oncology portfolio and contributions from new product launches. Management credited higher demand for KEYTRUDA in both early-stage and metastatic …

MRK main company

Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup negative 43.6%

00:16 13 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)

LivaNova PLC recently reported second-quarter 2026 results showing sales rising to US$390.59 million and net income climbing to US$108.57 million, alongside higher earnings per share versus a year earlier. On the back of this performance, the company raised its 2026 constant-currency revenue growth guidance …

TMO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +8.0%

23:09 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record …

TMO mentioned

Sharemaestro market context Price above Trend Line 52 weeks +8.0%

22:45 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider

Veeva Systems (VEEV) closed at $241.51 in the latest trading session, marking a +2.08% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.26% for the day. On the other hand, the Dow registered a loss of …

VEEV main company

Sharemaestro market context Price above Trend Line 52 weeks -29.9% · Next-week setup negative 31.2%

22:35 12 Aug 2026

seekingalpha.com Earnings Main company 🇲🇽 Mexico

FibroGen Q2 2026 Earnings Preview

* FibroGen (KYNB [https://seekingalpha.com/symbol/KYNB]) is scheduled to announce Q2 earnings results on Thursday, August 13th, after market close. * The consensus EPS estimate is -$3.18, [https://seekingalpha.com/symbol/KYNB/earnings/estimates] and the consensus revenue estimate is $2.01M (+48.9% Y/Y). * Over the last 3 months, EPS estimates have …

KYNB main company

Sharemaestro market context Price below Trend Line 52 weeks -19.6% · Next-week setup negative 24.9%

22:13 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Intuitive Surgical (ISRG) Beats On Q2 As Investors Ask If The Bull Case Is Priced In

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Intuitive Surgical (ISRG) shook investors after reporting strong Q2 2026 revenue and earnings that beat expectations, while revealing slower U.S. procedure growth and …

JNJ mentioned

Sharemaestro market context Trend signal active 52 weeks +32.5%

22:13 12 Aug 2026

finance.yahoo.com Market update Main company 🇲🇽 Mexico

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABT main company

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

22:10 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates

Staar Surgical (STAA) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

COO mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.9% · Next-week setup negative 25.0%

20:58 12 Aug 2026

finance.yahoo.com Analyst action Provider-linked mention 🇲🇽 Mexico

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

MRK mentioned

Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup negative 43.6%

20:30 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

These Are the Stocks Wall Street Is Betting Against the Most

This article first appeared on GuruFocus. The supplied source only contains the heatmap headline and ticker list, without the underlying short-interest percentages or ranking data. I can write the story accurately from that limited information, but I would not invent figures. A group of …

RXRX mentioned

Sharemaestro market context Price below Trend Line 52 weeks -48.1% · Next-week setup negative 27.6%

19:38 12 Aug 2026

seekingalpha.com Earnings Main company 🇲🇽 Mexico

Altimmune outlines PERFORMA Phase III MASH 52-week data readout expected in 2029 while advancing AUD Phase III planning

Earnings Call Insights: Altimmune (ALT) Q2 2026 MANAGEMENT VIEW * "2026 is proving to be a year of significant progress as Altimmune evolves into a late-stage company dedicated to serious liver diseases," said Chairman, CEO & President Jerome Durso, adding, "Last week we announced …

ALT1 main company

Sharemaestro market context Price below Trend Line 52 weeks -27.6% · Next-week setup negative 17.4%

19:36 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

19:36 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Is BMY's Growth Portfolio Strong Enough to Offset Legacy Drug Declines?

Bristol Myers Squibb BMY is navigating a revenue mix shift as growth products portfolio now assumes a larger role in the business, helping mitigate the impact of declining sales from mature products facing generics. The growth portfolio — including Opdivo, Opdivo Qvantig, Orencia, Yervoy, …

MRK mentioned PFE mentioned BMY mentioned

Sharemaestro market context Trend signal active 52 weeks +39.2% · Next-week setup negative 43.6%

19:34 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?

Intuitive Surgical ISRG has faced a moderation in U.S. procedure growth during the first half of 2026, but management's commentary suggests the slowdown is more likely a temporary demand-timing issue than evidence of a structural deterioration. U.S. da Vinci procedures grew 12% in the …

GMED mentioned

Sharemaestro market context Price below Trend Line 52 weeks +40.2% · Next-week setup negative 10.2%

19:33 12 Aug 2026

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

DXCM main company ABT mentioned

Sharemaestro market context Trend signal active 52 weeks -5.0% · Next-week setup negative 22.9%

19:33 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Can UNH's Lower Medical Costs Sustain the Earnings Recovery?

UnitedHealth Group Incorporated's UNH second-quarter results show that its earnings performance is improving. The medical care ratio (MCR) fell to 86.7% from 89.4% a year ago, meaning the company spent less of its premium revenues on medical care and retained more for profits. This …

UNH mentioned CVS mentioned

Sharemaestro market context Trend signal active 52 weeks +21.8%

19:13 12 Aug 2026

finance.yahoo.com Market update Main company 🇲🇽 Mexico

Gilead Sciences (GILD) Expands ADC Research With AI Tissue Analytics

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Gilead Sciences (NasdaqGS:GILD) announced a partnership with Nucleai to use AI-powered tissue analytics in its global antibody drug conjugate programs. The collaboration focuses …

GILD main company

Sharemaestro market context Price below Trend Line 52 weeks +4.3%

18:31 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

Sandbox VR Continues to Expand with its First North Carolina Venue in Winston-Salem, Opening August 14

Sandbox VR brings the 'best virtual reality experience on the planet' to Downtown Winston-Salem WINSTON-SALEM, N.C., Aug. 12, 2026 /PRNewswire/ -- Sandbox VR, the world's premier venue for virtual reality experiences, is set to open its first North Carolina location on August 14, 2026. …

CVS mentioned

Sharemaestro market context Trend signal active 52 weeks +45.1%

18:30 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇲🇽 Mexico

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

ABT mentioned

Sharemaestro market context Price above Trend Line 52 weeks -24.2% · Next-week setup negative 41.9%

18:29 12 Aug 2026

finance.yahoo.com Analyst action Main company 🇲🇽 Mexico

Berenberg Cuts Novo Nordisk as Lilly Takes the Oral Market

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the Danish drugmaker behind Wegovy and Ozempic, fell 2.23% intraday after Berenberg downgraded the stock to Hold from Buy, cutting its Copenhagen target to DKK 305 from DKK 325 and its ADR target to $47 …

NOVOBN main company NVON main company LLY mentioned

Sharemaestro market context Price above Trend Line 52 weeks -15.6%

18:24 12 Aug 2026

finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Eli Lilly Stock Falls While Retatrutide Lawsuits Expand

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the drug giant sitting at the center of the obesity boom, filed six lawsuits against businesses it says are illegally selling retatrutide. The timing is striking. Retatrutide is not approved. It is still in Phase …

LLY main company

Sharemaestro market context Trend signal active 52 weeks +54.2%

18:20 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇲🇽 Mexico

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

JNJ mentioned GMED mentioned

Sharemaestro market context Trend signal active 52 weeks +32.5%